Multiple Sclerosis Research News

September 29, 2023

Top Headlines

Marker for Brain Inflammation Finally Decoded

Sep. 25, 2023 — Inflammation is the sign that our body is defending itself against an aggression. But when this response escalates, for example in the brain, it can lead to serious neurological or psychiatric diseases. A team investigated a marker protein targeted ...

Possible Biomarker of MS-Like Autoimmune Disease Discovered

Aug. 8, 2023 — It has been known for several years that the diagnosis 'multiple sclerosis' conceals a whole range of different illnesses, each requiring customized treatment. Researchers have now described a possible new MS-like disease and explained how to ...

Treatment at the First Signs of MS Could Mean Lower Risk of Disability Later

July 19, 2023 — People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a new ...

Oral Medication Is the Leading Choice for Multiple Sclerosis Treatment

July 12, 2023 — Two injectable therapies accounted for nearly 100 percent of medications for patients in 2001, but by 2020 that decreased to about 25 ...

Latest Headlines

updated 11:28am EDT

Multiple Sclerosis: New Biomarker Confirmed for Early Diagnosis

July 6, 2023 — A study has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye. Use of the ...

Genetic Variant Linked With Faster Progression of Multiple Sclerosis

June 28, 2023 — A study of more than 22,000 people with multiple sclerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability ...

What Makes Multiple Sclerosis Worse, and How to Make It Better

June 28, 2023 — Scientists identify the first genetic marker for MS severity, opening the door to preventing long-term ...

Can This Medication Reverse MS? Brain Biomarker Shows It Can

June 12, 2023 — A decade after scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's effectiveness in repairing ...

Pregnancy Hormone Repairs Myelin Damage in MS Mouse Model

June 15, 2023 — A new study has identified a treatment that could repair myelin in the cortex, undoing some of the damage caused by ...

Children at Risk of Multiple Sclerosis Often Go Undetected in Early Stages

Mar. 16, 2023 — Criteria used by neurologists to assess for multiple sclerosis (MS) in adults may fail to identify the illness in children with imaging suspicious for the disease, an oversight that could delay ...

First Nasal Monoclonal Antibody Treatment for COVID-19 Shows Promise for Treating Virus, Other Diseases

Mar. 8, 2023 — A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence that the drug ...

Potential Treatment of Autoimmune Diseases Revealed in New Study

Mar. 6, 2023 — Scientists have uncovered a chemical compound that holds potential as a therapeutic for various autoimmune diseases, and they've used it to treat ...

Researcher Takes Another Step Toward Discovering How a Brain Molecule Could Halt MS

Feb. 1, 2023 — A researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of ...

Stem Cell Transplants May Delay Disability Longer Than Some MS Medications

Dec. 21, 2022 — In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a new study. The ...

Earlier Headlines

Summaries
Headlines

Light Therapy Relieves Fatigue Syndrome in Multiple Sclerosis

Dec. 12, 2022 — Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, ...

New Study Identifies Connection Between Diabetes Medications, Multiple Sclerosis

Nov. 18, 2022 — A study has found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among ...

Immune System Reboot in MS Patients

Nov. 10, 2022 — Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study has now examined in detail the way in which the treatment curbs the autoimmune disease and ...

Researchers Offer Roadmap for Identifying New Neuroprotective Treatments by Leveraging Sex Differences

Nov. 4, 2022 — Sex differences in the aging brain may offer an enticing clue for developing more effective neuroprotective treatments, according to a new research ...

Tofacitinib Shows Promise in Scleroderma Patients, Researchers Optimistic for Next Phase of Study

Oct. 6, 2022 — The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and ...

Study Advances Knowledge of Role of Brain Pathology and Cognitive Fatigue in Multiple Sclerosis

Oct. 6, 2022 — Researchers demonstrate the relationship between the rate of cognitive fatigue in MS and microstructural brain changes. The findings promise to advance development of clinical interventions for ...

Fish to Help in Search for MS Drugs

Sep. 20, 2022 — The zebrafish serves as a model organism for researchers around the world: it can be used to study important physiological processes that also take place in a similar form in the human body. It is ...

Simple Blood Test Predicts Neurotoxic Complications of CAR-T Cell Therapy

Sep. 1, 2022 — A new study suggests a simple blood test -- administered before CAR-T cell treatment is initiated -- may identify which patients are predisposed to developing neurotoxic side effects in the days and ...

Health Care Spending May Help Explain Link Between Multiple Sclerosis and Latitude

Aug. 24, 2022 — Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure. But countries farther from the ...

Quality of Life With Multiple Sclerosis May Depend on Several Factors

Aug. 10, 2022 — Quality of life is a measure of a person's level of comfort, health and happiness. For people with multiple sclerosis (MS), a new study has found there are specific factors that may affect a ...

Multiple Sclerosis Drug Works in a Surprising Way

Aug. 10, 2022 — Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding ...

Virtual Reality Technology Could Strengthen Effects of Traditional Rehabilitation for Multiple Sclerosis

July 6, 2022 — By increasing sensory input and promoting multisensory processing, virtual reality may increase the effectiveness of traditional cognitive rehabilitation and exercise training in individuals with MS, ...

Harnessing the Immune System to Treat Traumatic Brain Injury in Mice

May 26, 2022 — Researchers have designed a targeted therapeutic treatment that restricts brain inflammation. The effectiveness of this approach in improving outcomes was demonstrated following brain injury, stroke ...

Uncovering New Details of the Brain's First Line of Defense

May 20, 2022 — A research team has mapped out the development and genetic trajectory of previously understudied macrophages associated with the central nervous system. Among other things, the team found that ...

Multiple Sclerosis: Glatiramer Acetate Compatible With Breastfeeding, Study Suggests

May 11, 2022 — For patients suffering from multiple sclerosis (MS), becoming a mother is fraught with difficult questions: is it acceptable to continue disease modifying treatment during pregnancy and breastfeeding ...

Findings Open Way for Personalized MS Treatment

Apr. 27, 2022 — Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers have now developed a method for identifying the immune cells involved ...

A New Treatment Reduces Inflammation in Multiple Sclerosis Mice Models

Apr. 26, 2022 — Researchers managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates ...

Could Releasing ‘handbrake’ Immune Cells Help Supercharge Immunity?

Apr. 14, 2022 — Researchers have found a way to supercharge immune cells that could enable them to clear disease and infections ...

Total Economic Burden of MS in United States Is More Than $85 Billion

Apr. 13, 2022 — The estimated cost of multiple sclerosis (MS) reached $85.4 billion in 2019 in the United States, according to a new report. In addition, when researchers compared people with MS to people without MS ...

Behavioral Treatment for Deficits of Facial Affect Recognition in Multiple Sclerosis

Apr. 12, 2022 — A recent study has demonstrated efficacy for the behavioral intervention, EMOPRINT, for treating deficits of facial recognition in individuals with multiple sclerosis (MS). The study provides Class I ...

Monday, December 12, 2022